Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB26FX4HZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,974
Award facts
- Contract value 100% obligated
- $96,973.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of KEVZARA 200 mg/1.14 ml pen injections valued at $96,973.81 under a firm fixed price contract. This non-set-aside award, which is scheduled for completion by November 5, 2025, represents a child delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. KEVZARA is a biologic medication used in the treatment of rheumatoid arthritis, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare needs.
This delivery order is part of AmerisourceBergen's extensive federal pharmaceutical supply portfolio with the Defense Logistics Agency, leveraging the company's $999,999,999.00 master indefinite delivery contract through December 2026. AmerisourceBergen is a major pharmaceutical distributor that consistently wins competitively awarded contracts to supply a comprehensive range of medications and medical supplies across multiple therapeutic areas to support Defense Health Agency operations and other federal healthcare systems. The company's continued engagement in DLA medical supply procurement underscores its critical role in the federal government's pharmaceutical distribution network for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX4HZ?
SPE2DB26FX4HZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FX4HZ worth?
The government has obligated $96,974 on SPE2DB26FX4HZ.
Is contract SPE2DB26FX4HZ an order under another contract?
Yes. SPE2DB26FX4HZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4HZ competed?
The extent of competition for SPE2DB26FX4HZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award